Table 1.
Age median, (IQR) years | 30 (6) |
Any Comorbidity – no. (%) | 1 (7.1) |
Dyspnea – no. (%) | 11 (78.6) |
Cough – no. (%) | 9 (64.3) |
Fever – no. (%) | 5 (35.7) |
Fatigue – no. (%) | 5 (35.7) |
Back pain – no. (%) | 3 (21.4) |
Myalgia – no. (%) | 3 (21.4) |
Diarrhea – no. (%) | 2 (14.3) |
Throat ache – no. (%) | 2 (14.3) |
Abdominal pain – no. (%) | 1 (7.1) |
Headache – no. (%) | 1 (7.1) |
Nausea and vomiting – no. (%) | 1 (7.1) |
Anosmi – no. (%) | 1 (7.1) |
Taste disturbance – no. (%) | 1 (7.1) |
Pregnancy week at diagnosis median, (IQR) | 24.5 (9.25) |
Inpatient duration – median (IQR) days | 15 (7.5) |
Need for oxygen – no. (%) | 12 (85.7) |
Intensive care unit – no. (%) | 4 (28.6) |
Invasive mechanical ventilation – no. (%) | 3 (21.4) |
Fetal complication – no. (%) | 2 (16.7) |
Anakinra starting dose median, (IQR) mg | 400 (75) |
Steroid starting dose median, (IQR) mg | 80 (90.5) |
Deceased – no. (%) | 1 (7.1) |